LENZ Therapeutics LENZ
NASDAQ LENZ
$3.58 -0.21 (-5.54%)
At close: Oct 2, 2026 · 4:00 PM EDT

LENZ Therapeutics (LENZ) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

LENZ Therapeutics' Return on Capital Employed [ROCE] came in at -57.15% for Q2 2026, down 26.00 percentage points from -31.15% a year earlier and down 12.23 percentage points from the prior quarter.

Analysis

LENZ Therapeutics (LENZ) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, LENZ Therapeutics' Return on Capital Employed [ROCE] was -38.07%, up 6.19 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a four-year change of -7.87 percentage points (FY2021 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -44.26% in FY2024 (-3.48 pp), -40.78% in FY2023 (-10.50 pp), -30.28% in FY2022 (-0.08 pp) and -30.20% in FY2021.
  • The Q2 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] since Q1 2024.
  • Year-over-year, Return on Capital Employed [ROCE] has declined for four consecutive quarters, with an average year-over-year change of -0.04 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q1 2025 (a gain of 30.97 percentage points), and the weakest in Q1 2024 (a drop of 30.14 percentage points).
  • Business Quant data shows LENZ's Return on Capital Employed [ROCE] at -44.93% (Q1 2026), -38.44% (Q4 2025) and -34.34% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 LENZ Therapeutics 112.47 Mn 112.47 Mn 5.21 Mn -57.15%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -57.15%
Mar 31, 2026 -44.93%
Dec 31, 2025 -38.44%
Sep 30, 2025 -34.34%
Jun 30, 2025 -31.15%
Mar 31, 2025 -29.77%
Dec 31, 2024 -28.01%
Sep 30, 2024 -33.25%
Jun 30, 2024 -37.39%
Mar 31, 2024 -60.74%
Dec 31, 2023 -48.35%
Sep 30, 2023 -28.09%
Jun 30, 2023 -28.12%
Mar 31, 2023 -30.60%
Dec 31, 2022 -33.50%
Sep 30, 2022 -29.57%
Jun 30, 2022 -24.36%
Mar 31, 2022 -20.40%
Dec 31, 2021 -15.23%
Sep 30, 2021 -12.76%
API Access

LENZ Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LENZ&period=max&api_key=YOUR_API_KEY